Accessibility Menu
Viveve Medical logo

Viveve Medical(OTC) VIVE

Market Cap$2.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)-100%
5 Year-100%
1 Year+100%
1 Month+0%
$0.00
+0.00%
+0.00Today
Viveve Medical last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-13
Viveve Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-08-06
1 month+0%USD 0.002026-07-14
3 month+0%USD 0.002026-05-14
Year to date+100%USD 0.002025-12-31
1 year+100%USD 0.002025-08-12
3 year-94.29%USD 0.002023-08-14
5 year-99.99%USD 2.402021-08-13
Since inception-100%USD 4,400,000.001992-06-15

Viveve Medical Financials at a Glance

Market Cap

$2.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$6.83M

Net Income (TTM)

-$23.92M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-75.60 (Low)

Price

$0.00

Volume

1,167

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 14, 2026

VIVE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Viveve Medical

Viveve Medical, Inc. is a healthcare-focused company that develops innovative software solutions aimed at streamlining human resources operations for healthcare organizations. The company offers an all-in-one platform designed to enhance employee management and recruitment processes, ultimately improving the overall employee experience.

Products and Services
  • Comprehensive HR software solutions for healthcare organizations
  • Employee management and recruitment tools
  • Specialized solutions for mental and behavioral health sectors
Growth Outlook
  • Recent quarterly revenue of $1.68 million shows potential for growth
  • Current ratio of 4.91 indicates strong liquidity position
  • Cash reserves of $5.91 million provide a buffer for future investments
Financial Highlights
  • Trailing twelve months (TTM) revenue of $6.5 million reflects steady performance
  • Net income for Q3 2022 was -$5.29 million, indicating ongoing investment in growth
  • Operating cash flow for Q3 2022 was -$3.35 million, highlighting cash management challenges
Viveve Medical, Inc. operates in the medical devices industry, focusing on enhancing HR operations within healthcare settings. The company's innovative software solutions are tailored to meet the unique needs of healthcare organizations, particularly in recruitment and employee management. With a strong liquidity position, as indicated by a current ratio of 4.91, Viveve is well-positioned to navigate the challenges of the healthcare market. The recent quarterly revenue of $1.68 million demonstrates the company's ability to generate income, while the trailing twelve months revenue of $6.5 million reflects a consistent performance trend. However, the net income of -$5.29 million for Q3 2022 suggests that the company is still in a growth phase, investing heavily in its future. The operating cash flow of -$3.35 million indicates that cash management remains a critical area for improvement. Overall, Viveve Medical, Inc. presents an intriguing opportunity for investors interested in the healthcare technology sector, particularly those focused on innovative solutions that enhance operational efficiency in healthcare organizations.
AI Generated • Jul 21, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

47

CEO

Scott C. Durbin

Website

www.viveve.com

Headquarters

Englewood, CO 80112, US

VIVE Financials

Key Financial Metrics (TTM)

Gross Margin

9.65%

Operating Margin

-335.40%

Net Income Margin

-342.78%

Return on Equity

-199.88%

Return on Capital

-105.57%

Return on Assets

-85.00%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

10.72M

Volume

1.17K

Avg. Volume

1.55K

Financials (TTM)

Gross Profit

$1.12M

Operating Income

-$21.14M

EBITDA

-$20.43M

Operating Cash Flow

-$16.23M

Capital Expenditure

-$595.00K

Free Cash Flow

-$16.83M

Cash & ST Invst.

$5.91M

Total Debt

$5.88M

Viveve Medical Performance Analysis

Viveve Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 6,426,000N/A
Viveve Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42021-12-315.6%
Q12022-03-31-3.8%
Q22022-06-309.4%
Q32022-09-30-6.2%
Viveve Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -2.65N/A
Viveve Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42021-12-31-14.5%
Q12022-03-317.9%
Q22022-06-30N/A
Q32022-09-3013.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2022YOY CHG

Revenue

$1.68M

+4.2%

Gross Profit

$546.00K

+378.9%

Gross Margin

32.42%

N/A

Market Cap

$2.10KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$44.68

N/A

Employees

47

N/A

Net Income

-$5.29M

+9.7%

EBITDA

-$4.51M

+15.3%

Quarterly Fundamentals

Name
Q3 2022YOY CHG

Total Cash

$5.91M

-73.9%

Total Debt

$5.88M

+13.6%

Accounts Receivable

$860.00K

+67.3%

Inventory

$1.62M

-24.9%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$5.88M

+2648.1%

Return on Assets

-85.00%

N/A

Return on Invested Capital

-1.01%

N/A

Free Cash Flow

-$3.54M

-29.0%

Operating Cash Flow

-$3.35M

-25.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TNGNQTengion, Inc.
$0.00-90.00%
NMRDNemaura Medical Inc.
$0.00+0.00%
KLDOKaleido Biosciences, Inc.
$0.00+0.00%
BXRXQBaudax Bio, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.91-0.09%
SMCISuper Micro Computer
$39.16+0.04%
SPCXSpace Exploration Technologies
$141.29-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.64+0.07%

Questions About VIVE

What is the current price of Viveve Medical?

Viveve Medical is trading at $0.00 per share.

What is the 52-week range for Viveve Medical?

Over the past 52 weeks, Viveve Medical has traded between $0.00 and $0.00.

How much debt does Viveve Medical have?

As of the most recent reporting period, Viveve Medical reported total debt of $5.68M.

How much cash does Viveve Medical have on hand?

Viveve Medical reported $19.16M in cash and cash equivalents in its most recent financial results.

What is Viveve Medical’s dividend yield?

Viveve Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services